ArticleThe Journal of dermatology2026
An Attempt to Establish the Consensus Regarding the Diagnosis, Classification, and Treatment of Rosacea in Japan Using a Modified Delphi Method: The Japan Rosacea Consensus.
Article in The Journal of dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Topical Calcineurin Inhibitors in Rosacea: Potential Benefit in Selected Clinical Settings and Risk of Rosaceiform Dermatitis.Clinical, cosmetic and investigational dermatology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
In Japan, rosacea has attracted increasing interest. However, because rosacea had been thought to be relatively rare in Japan, the perception of this disease varies among dermatologists. To address these challenges, this study developed a consensus regarding the diagnosis, classification, and treatment of rosacea using a modified Delphi method based on the expertise of Japanese specialists in rosacea. Ten Japanese dermatologists were included in the expert panel based on their expertise in rosacea treatment and contributions to the field of rosacea. For each item that mentioned rosacea, the specialists responded with "disagree," "neither agree nor disagree," "agree," or "don't know/can't answer." Consensus was defined as ≥ 80% agreement among panel members. Panel consensus was obtained for all 50 items related to rosacea (e.g., disease types, characteristics, diagnosis, factors for onset and exacerbation, and treatment). An online survey on the consensus statements revealed discrepancies between general dermatologists and panel members. In the postsurvey meeting, the panel members discussed the differentiation between rosacea and similar diseases and proposed an algorithm for differentiating rosacea. The panel members concluded that the goal of rosacea treatment in Japan should be to "maintain a state wherein the patient's daily life is not affected by symptoms over the long term" rather than "complete cure." Thus, this study integrated the findings of the expert panel and proposed a consensus statement on rosacea treatment in Japan. The organization of knowledge and dissemination of information regarding rosacea among general dermatologists will improve the treatment outcomes of patients with rosacea.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.